Horizon’s Quest on Resolving Variant of Uncertain Significance (VUS)

The average human genome encompasses over 4 million variants, impacting a vast array of more than 20,000 protein-coding genes. Unraveling the significance of each variant in human

Interpretation of Rare Genetic Diseases through Machine Learning-Based Automation

In recent years, the area of genetics has advanced significantly, particularly in the identification of previously unknown and rare disorders. However, the intricacy and quantity of genomic

Watch our Recent Webinar on Clinical Genetic Testing

To discuss the impact of genetic tests in the clinic, we have Dr. Marc Woodburry-Smith who is a globally renowned neuropsychiatrist and Senior Lecturer at Bioscience Institute

Clinical Genetic Testing: Insights from a Clinicain-Scientist in a Pediatric Neurodevelopmental Clinic

Neurodevelopmental disorders is a broad umbrella term that include autism spectrum disorders, epilepsy encephalopathy, intellectual disabilities and other broader neurodevelopmental delays.

Watch our Recent Webinar on Transforming Patients Lives

Exciting discussion where Dr. Mohammed Uddin Dafil a Canadian geneticist who founded GenomeArc discusses the current technologies that are critical in interpreting genomes for clinical impact.

Interpreting Genome to Transform Patients' Lives: A Discussion on Genome Automation for Diagnosis

Genome interpretation is the most complex bottleneck for clinical diagnosis, therapeutics and drug targets. Recent advancement of genome sequencing technologies are now providing labs with power to pr...

GenomeArc Unveils Horizon: Groundbreaking Genome Interpretation Platform, Enabling Early Diagnosis and Therapeutic Intervention

GenomeArc Inc., a leading biotech organization, is proud to announce the release of its cutting-edge genome interpretation software - Horizon, revolutionizing the field of genetic analysis. This break...

GenomeArc Announces Early Access Program for Horizon Platform, AI Integrated Rare Disease and Cancer Solution

GenomeArc Inc. is a biotech company on clinical genetics and drug discovery, and we enforce the development of fast algorithms to interpret genomic data through our flagship Horizon platform

Understanding the Long Read Whole Genome Analysis Bottleneck: Interpretation

High throughput genome sequencing is approaching into clinics at a lightning pace. Recent advancement on the long read sequencing technologies made it possible to decipher many inaccessible biological...

International Collaborations on the Validation Effort of Horizon Genome Analytics Platform for Rare Genetic Disorders

Horizon is a rapid whole genome analytic platform that annotates, classifies, and interprets variants in relation to patient phenotypic data. The platform serves as a complete solution for rare geneti...

GenomeArc Inc. hold the First Meeting of its international Scientific Advisory Board

The meeting brought together for the first time the whole panel of GenomeArc Inc. scientific advisory board (SAB) members, a group of scientists who are leaders on clinical genetic diagnosis